Short Interest in Celcuity Inc. (NASDAQ:CELC) Drops By 7.5%

Celcuity Inc. (NASDAQ:CELC) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 1,860,000 shares, a decline of 7.5% from the March 15th total of 2,010,000 shares. Based on an average daily trading volume, of 230,800 shares, the days-to-cover ratio is presently 8.1 days.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. HC Wainwright reissued a “buy” rating and set a $27.00 price objective on shares of Celcuity in a report on Thursday, March 28th. Stifel Nicolaus initiated coverage on Celcuity in a research note on Thursday, February 22nd. They set a “buy” rating and a $40.00 price objective for the company. Needham & Company LLC restated a “buy” rating and set a $24.00 target price on shares of Celcuity in a report on Friday. Finally, Craig Hallum upped their target price on Celcuity from $20.00 to $25.00 and gave the company a “buy” rating in a report on Thursday, March 28th.

Institutional Trading of Celcuity

Large investors have recently added to or reduced their stakes in the company. Barclays PLC purchased a new stake in shares of Celcuity in the 2nd quarter worth $37,000. Bank of America Corp DE increased its position in Celcuity by 40.3% during the 4th quarter. Bank of America Corp DE now owns 3,159 shares of the company’s stock valued at $44,000 after buying an additional 907 shares in the last quarter. BNP Paribas Arbitrage SNC increased its position in Celcuity by 9,962.2% during the 2nd quarter. BNP Paribas Arbitrage SNC now owns 4,528 shares of the company’s stock valued at $50,000 after buying an additional 4,483 shares in the last quarter. California State Teachers Retirement System acquired a new position in Celcuity during the 2nd quarter valued at about $63,000. Finally, JPMorgan Chase & Co. acquired a new position in Celcuity during the 4th quarter valued at about $70,000. Institutional investors own 63.33% of the company’s stock.

Celcuity Stock Performance

Shares of NASDAQ CELC traded down $0.86 during trading on Tuesday, hitting $17.23. The company had a trading volume of 67,930 shares, compared to its average volume of 216,946. The stock has a 50 day simple moving average of $17.47 and a 200 day simple moving average of $14.46. The company has a debt-to-equity ratio of 0.26, a quick ratio of 13.43 and a current ratio of 13.43. Celcuity has a 12 month low of $8.39 and a 12 month high of $22.19. The firm has a market capitalization of $524.65 million, a P/E ratio of -6.41 and a beta of 0.78.

About Celcuity

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.